nature.com search

Loading Filters

Showing 1–37 of 37 results

Loading Filters

Research | 30 September 2020 | Open
NOTCH1 is critical for fibroblast-mediated induction of cardiomyocyte specialization into ventricular conduction system-like cells in vitro
Scientific Reports 10 , 1–18

Rights & permissionsfor article NOTCH1 is critical for fibroblast-mediated induction of cardiomyocyte specialization into ventricular conduction system-like cells in vitro . Opens in a new window.
Research | 23 July 2020 | Open
Beneficial effects of IL-4 and IL-6 on rat neonatal target cardiac cells
Scientific Reports 10 , 1–12

Rights & permissionsfor article Beneficial effects of IL-4 and IL-6 on rat neonatal target cardiac cells . Opens in a new window.
Research | 11 January 2019
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia
- G. Reda
- , R. Cassin
- , M. Gentile
- , F. R. Mauro
- , D. Giannarelli
- , B. Fattizzo
- , M. Barbieri
- , I. Silvestris
- , S. Fabris
- , F. Morabito
- , A. Neri
- , W. Barcellini
- & A. Cortelezzi
Leukemia 33 , 1519–1522

Rights & permissionsfor article IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia . Opens in a new window.
6 December 2017 | Open
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines
- F Maura
- , M Petljak
- , M Lionetti
- , I Cifola
- , W Liang
- , E Pinatel
- , L B Alexandrov
- , A Fullam
- , I Martincorena
- , K J Dawson
- , N Angelopoulos
- , M K Samur
- , R Szalat
- , J Zamora
- , P Tarpey
- , H Davies
- , P Corradini
- , K C Anderson
- , S Minvielle
- , A Neri
- , H Avet-Loiseau
- , J Keats
- , P J Campbell
- , N C Munshi
- & N Bolli
Leukemia 32 , 1043–1047

Rights & permissionsfor article Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines . Opens in a new window.
6 January 2017 | Open
Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression
- G Barisione
- , M Fabbi
- , G Cutrona
- , L De Cecco
- , S Zupo
- , B Leitinger
- , M Gentile
- , M Manzoni
- , A Neri
- , F Morabito
- , M Ferrarini
- & S Ferrini
Blood Cancer Journal 7 , e513–e513

Rights & permissionsfor article Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression . Opens in a new window.
20 August 2013
Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia
- P Musto
- , V Simeon
- , M C Martorelli
- , M T Petrucci
- , N Cascavilla
- , F Di Raimondo
- , T Caravita
- , F Morabito
- , M Offidani
- , A Olivieri
- , G Benevolo
- , R Mina
- , R Guariglia
- , G D'Arena
- , G Mansueto
- , N Filardi
- , F Nobile
- , A Levi
- , A Falcone
- , M Cavalli
- , G Pietrantuono
- , O Villani
- , S Bringhen
- , P Omedè
- , R Lerose
- , L Agnelli
- , K Todoerti
- , A Neri
- , M Boccadoro
- & A Palumbo
Leukemia 28 , 222–225

Rights & permissionsfor article Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia . Opens in a new window.
9 December 2015
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients
- M Gentile
- , T D Shanafelt
- , G Cutrona
- , S Molica
- , G Tripepi
- , I Alvarez
- , F R Mauro
- , N Di Renzo
- , F Di Raimondo
- , I Vincelli
- , K Todoerti
- , S Matis
- , C Musolino
- , S Fabris
- , E Vigna
- , L Levato
- , S Zupo
- , F Angrilli
- , U Consoli
- , G Festini
- , G Longo
- , A Cortelezzi
- , A Arcari
- , M Federico
- , D Mannina
- , A G Recchia
- , A Neri
- , N E Kay
- , M Ferrarini
- & F Morabito
Leukemia 30 , 1440–1443

Rights & permissionsfor article A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients . Opens in a new window.
Research | 13 November 2013
Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial
- A Cortelezzi
- , M Sciumè
- , A M Liberati
- , D Vincenti
- , A Cuneo
- , G Reda
- , L Laurenti
- , F Zaja
- , R Marasca
- , A Chiarenza
- , G Gritti
- , L Orsucci
- , S Storti
- , E Angelucci
- , N Cascavilla
- , M Gobbi
- , F R Mauro
- , F Morabito
- , S Fabris
- , A Piciocchi
- , M Vignetti
- , A Neri
- , D Rossi
- , D Giannarelli
- , A Guarini
- & R Foà
Leukemia 28 , 642–648

Rights & permissionsfor article Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial . Opens in a new window.
6 October 2014
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma
- R Piva
- , S Deaglio
- , R Famà
- , R Buonincontri
- , I Scarfò
- , A Bruscaggin
- , E Mereu
- , S Serra
- , V Spina
- , D Brusa
- , G Garaffo
- , S Monti
- , M Dal Bo
- , R Marasca
- , L Arcaini
- , A Neri
- , V Gattei
- , M Paulli
- , E Tiacci
- , F Bertoni
- , S A Pileri
- , R Foà
- , G Inghirami
- , G Gaidano
- & D Rossi
Leukemia 29 , 503–507

Rights & permissionsfor article The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma . Opens in a new window.
9 August 2012
Prognostic factors in CLL
- M Ferrarini
- , G Cutrona
- , A Neri
- & F Morabito
Leukemia Supplements 1 , S29–S30

Rights & permissionsfor article Prognostic factors in CLL . Opens in a new window.
Correspondence | 14 June 2001
Characterization of the t(4;14)(p16.3;q32) in the KMS-18 multiple myeloma cell line
- D Ronchetti
- , S Bogni
- , P Finelli
- , L Lombardi
- , T Otsuki
- , AT Maiolo
- & A Neri
Leukemia 15 , 864–865

Rights & permissionsfor article Characterization of the t(4;14)(p16.3;q32) in the KMS-18 multiple myeloma cell line . Opens in a new window.
Research | 21 February 2002
Transient dynamics of vulcanian explosions and column collapse
- A. B. Clarke
- , B. Voight
- , A. Neri
- & G. Macedonio
Nature 415 , 897–901

Rights & permissionsfor article Transient dynamics of vulcanian explosions and column collapse . Opens in a new window.
20 May 2010
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients
- N Giuliani
- , G Lisignoli
- , F Novara
- , P Storti
- , N Zaffaroni
- , R Villa
- , G Sammarelli
- , L Agnelli
- , K Todoerti
- , M E Bernardo
- , C Manferdini
- , S Colla
- , M Abeltino
- , M Bolzoni
- , A Rocci
- , E Gabusi
- , A Palumbo
- , O Zuffardi
- , A Neri
- & V Rizzoli
Leukemia 24 , 1368–1370

Rights & permissionsfor article Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients . Opens in a new window.
22 February 2007
Transcriptional features of multiple myeloma patients with chromosome 1q gain
- S Fabris
- , D Ronchetti
- , L Agnelli
- , L Baldini
- , F Morabito
- , S Bicciato
- , D Basso
- , K Todoerti
- , L Lombardi
- , G Lambertenghi-Deliliers
- & A Neri
Leukemia 21 , 1113–1116

Rights & permissionsfor article Transcriptional features of multiple myeloma patients with chromosome 1q gain . Opens in a new window.
7 March 2000
Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas
- F Bertoni
- , A Conconi
- , S Luminari
- , C Realini
- , E Roggero
- , L Baldini
- , S Carobbio
- , F Cavalli
- , A Neri
- & E Zucca
Leukemia 14 , 446–448

Rights & permissionsfor article Lack of <i>CD95/FAS</i> gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas . Opens in a new window.
28 April 2000
BCL10 gene mutations rarely occur in lymphoid malignancies
- S Luminari
- , D Intini
- , L Baldini
- , E Berti
- , F Bertoni
- , E Zucca
- , L Cro
- , AT Maiolo
- , F Cavalli
- & A Neri
Leukemia 14 , 905–908

Rights & permissionsfor article <i>BCL10</i> gene mutations rarely occur in lymphoid malignancies . Opens in a new window.
Research | 13 April 2004 | Open
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma
- P Correale
- , S Messinese
- , M Caraglia
- , S Marsili
- , A Piccolomini
- , R Petrioli
- , F Ceciarini
- , L Micheli
- , C Nencini
- , A Neri
- , G Vuolo
- , A Guarnieri
- , A Abbruzzese
- , S D Prete
- , G Giorgi
- & G Francini
British Journal of Cancer 90 , 1710–1714

Rights & permissionsfor article A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma . Opens in a new window.
3 January 2003
Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias
- L Cro
- , A Guffanti
- , M Colombi
- , B Cesana
- , M G Grimoldi
- , C Patriarca
- , M Goldaniga
- , A Neri
- , D Intini
- , A Cortelezzi
- , A T Maiolo
- & L Baldini
Leukemia 17 , 125–132

Rights & permissionsfor article Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias . Opens in a new window.
2 September 2010
Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138⁺ cells
- S Colla
- , P Storti
- , G Donofrio
- , K Todoerti
- , M Bolzoni
- , M Lazzaretti
- , M Abeltino
- , L Ippolito
- , A Neri
- , D Ribatti
- , V Rizzoli
- , E Martella
- & N Giuliani
Leukemia 24 , 1967–1970

Rights & permissionsfor article Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138<sup>+</sup> cells . Opens in a new window.
Correspondence | 5 June 2002
A novel mutation involving the carboxy terminal region of the FGFR3 gene in a multiple myeloma patient with t(4;14)
- D Intini
- , L Baldini
- , L Lombardi
- & A Neri
Leukemia 16 , 1201–1202

Rights & permissionsfor article A novel mutation involving the carboxy terminal region of the <i>FGFR3</i> gene in a multiple myeloma patient with t(4;14) . Opens in a new window.
Research | 30 July 2009
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study
- A Cortelezzi
- , M C Pasquini
- , A Gardellini
- , U Gianelli
- , A Bossi
- , G Reda
- , B Sarina
- , P Musto
- , W Barcellini
- , A Neri
- & G L Deliliers
Leukemia 23 , 2027–2033

Rights & permissionsfor article Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study . Opens in a new window.
Research | 15 July 2003 | Open
A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid
- P Correale
- , S Messinese
- , S Marsili
- , F Ceciarini
- , D Pozzessere
- , R Petrioli
- , M Sabatino
- , D Cerretani
- , M Pellegrini
- , T Di Palma
- , A Neri
- , A Calvanese
- , E Pinto
- , G Giorgi
- & G Francini
British Journal of Cancer 89 , 239–242

Rights & permissionsfor article A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid . Opens in a new window.
30 January 2012
Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?
- L Scarfò
- , S Zibellini
- , A Tedeschi
- , F Maura
- , A Neri
- , P Bertazzoni
- , B Sarina
- , G Nalli
- , M Motta
- , F Rossini
- , A Cortelezzi
- , M Montillo
- , E Orlandi
- & P Ghia
Leukemia 26 , 1703–1707

Rights & permissionsfor article Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? . Opens in a new window.
Research | 20 May 2016
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo
- P Storti
- , V Marchica
- , I Airoldi
- , G Donofrio
- , E Fiorini
- , V Ferri
- , D Guasco
- , K Todoerti
- , R Silbermann
- , J L Anderson
- , W Zhao
- , L Agnelli
- , M Bolzoni
- , E Martella
- , C Mancini
- , N Campanini
- , D M Noonan
- , P G Petronini
- , A Neri
- , F Aversa
- , G D Roodman
- & N Giuliani
Leukemia 30 , 2351–2363

Rights & permissionsfor article Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth <i>in vivo</i> . Opens in a new window.
Research | 5 January 2017
Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy
- G Cutrona
- , S Matis
- , M Colombo
- , C Massucco
- , G Baio
- , F Valdora
- , L Emionite
- , S Fabris
- , A G Recchia
- , M Gentile
- , C E Neumaier
- , D Reverberi
- , R Massara
- , S Boccardo
- , L Basso
- , S Salvi
- , F Rosa
- , M Cilli
- , S Zupo
- , M Truini
- , P Tassone
- , M Calabrese
- , M Negrini
- , A Neri
- , F Morabito
- , F Fais
- & M Ferrarini
Leukemia 31 , 1894–1904

Rights & permissionsfor article Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy . Opens in a new window.
Research | 9 September 2016 | Open
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome
- D Ronchetti
- , M Manzoni
- , L Agnelli
- , C Vinci
- , S Fabris
- , G Cutrona
- , S Matis
- , M Colombo
- , S Galletti
- , E Taiana
- , A G Recchia
- , S Bossio
- , M Gentile
- , C Musolino
- , F Di Raimondo
- , A Grilli
- , S Bicciato
- , A Cortelezzi
- , P Tassone
- , F Morabito
- , M Ferrarini
- & A Neri
Blood Cancer Journal 6 , e468–e468

Rights & permissionsfor article lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome . Opens in a new window.
Research | 15 January 2016 | Open
miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth
- M Fulciniti
- , N Amodio
- , R L Bandi
- , A Cagnetta
- , M K Samur
- , C Acharya
- , R Prabhala
- , P D'Aquila
- , D Bellizzi
- , G Passarino
- , S Adamia
- , A Neri
- , Z R Hunter
- , S P Treon
- , K C Anderson
- , P Tassone
- & N C Munshi
Blood Cancer Journal 6 , e380–e380

Rights & permissionsfor article miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth . Opens in a new window.
Research | 19 May 2015 | Open
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
- E Morelli
- , E Leone
- , M E Gallo Cantafio
- , M T Di Martino
- , N Amodio
- , L Biamonte
- , A Gullà
- , U Foresta
- , M R Pitari
- , C Botta
- , M Rossi
- , A Neri
- , N C Munshi
- , K C Anderson
- , P Tagliaferri
- & P Tassone
Leukemia 29 , 2173–2183

Rights & permissionsfor article Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity <i>in vitro</i> and <i>in vivo</i> . Opens in a new window.
Research | 16 July 2012
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer
- T Ezponda
- , R Popovic
- , M Y Shah
- , E Martinez-Garcia
- , Y Zheng
- , D-J Min
- , C Will
- , A Neri
- , N L Kelleher
- , J Yu
- & J D Licht
Oncogene 32 , 2882–2890

Rights & permissionsfor article The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer . Opens in a new window.
1 October 2009
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
- R Fonseca
- , P L Bergsagel
- , J Drach
- , J Shaughnessy
- , N Gutierrez
- , A K Stewart
- , G Morgan
- , B Van Ness
- , M Chesi
- , S Minvielle
- , A Neri
- , B Barlogie
- , W M Kuehl
- , P Liebisch
- , F Davies
- , S Chen-Kiang
- , B G M Durie
- , R Carrasco
- , Orhan Sezer
- , Tony Reiman
- , Linda Pilarski
- & H Avet-Loiseau
Leukemia 23 , 2210–2221

Rights & permissionsfor article International Myeloma Working Group molecular classification of multiple myeloma: spotlight review . Opens in a new window.
Research | 23 November 2012 | Open
The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma
- D Ronchetti
- , K Todoerti
- , G Tuana
- , L Agnelli
- , L Mosca
- , M Lionetti
- , S Fabris
- , P Colapietro
- , M Miozzo
- , M Ferrarini
- , P Tassone
- & A Neri
Blood Cancer Journal 2 , e96–e96

Rights & permissionsfor article The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma . Opens in a new window.
Research | 29 November 2012 | Open
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
- N Amodio
- , M T Di Martino
- , U Foresta
- , E Leone
- , M Lionetti
- , M Leotta
- , A M Gullà
- , M R Pitari
- , F Conforti
- , M Rossi
- , V Agosti
- , M Fulciniti
- , G Misso
- , F Morabito
- , M Ferrarini
- , A Neri
- , M Caraglia
- , N C Munshi
- , K C Anderson
- , P Tagliaferri
- & P Tassone
Cell Death & Disease 3 , e436–e436

Rights & permissionsfor article miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 . Opens in a new window.
Research | 6 January 2012
Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation
- N Giuliani
- , M Ferretti
- , M Bolzoni
- , P Storti
- , M Lazzaretti
- , B Dalla Palma
- , S Bonomini
- , E Martella
- , L Agnelli
- , A Neri
- , F Ceccarelli
- & C Palumbo
Leukemia 26 , 1391–1401

Rights & permissionsfor article Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation . Opens in a new window.
Research | 11 July 2012
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells
- M Bolzoni
- , G Donofrio
- , P Storti
- , D Guasco
- , D Toscani
- , M Lazzaretti
- , S Bonomini
- , L Agnelli
- , A Capocefalo
- , B Dalla Palma
- , A Neri
- , F Nicolini
- , G Lisignoli
- , F Russo
- , S Colla
- , F Aversa
- & N Giuliani
Leukemia 27 , 451–463

Rights & permissionsfor article Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells . Opens in a new window.
Research | 23 November 2010
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients
- P Storti
- , G Donofrio
- , S Colla
- , I Airoldi
- , M Bolzoni
- , L Agnelli
- , M Abeltino
- , K Todoerti
- , M Lazzaretti
- , C Mancini
- , D Ribatti
- , S Bonomini
- , V Franceschi
- , V Pistoia
- , G Lisignoli
- , A Pedrazzini
- , O Cavicchi
- , A Neri
- , V Rizzoli
- & N Giuliani
Leukemia 25 , 527–537

Rights & permissionsfor article HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients . Opens in a new window.
Research | 19 July 2007
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells
- J Golay
- , L Cuppini
- , F Leoni
- , C Micò
- , V Barbui
- , M Domenghini
- , L Lombardi
- , A Neri
- , A M Barbui
- , A Salvi
- , P Pozzi
- , G Porro
- , P Pagani
- , G Fossati
- , P Mascagni
- , M Introna
- & A Rambaldi
Leukemia 21 , 1892–1900

Rights & permissionsfor article The histone deacetylase inhibitor ITF2357 has anti-leukemic activity <i>in vitro</i> and <i>in vivo</i> and inhibits IL-6 and VEGF production by stromal cells . Opens in a new window.
Research | 24 January 2013
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
- P Storti
- , M Bolzoni
- , G Donofrio
- , I Airoldi
- , D Guasco
- , D Toscani
- , E Martella
- , M Lazzaretti
- , C Mancini
- , L Agnelli
- , K Patrene
- , S Maïga
- , V Franceschi
- , S Colla
- , J Anderson
- , A Neri
- , M Amiot
- , F Aversa
- , G David Roodman
- & N Giuliani
Leukemia 27 , 1697–1706

Rights & permissionsfor article Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth <i>in vivo</i> inhibiting angiogenesis and bone destruction . Opens in a new window.

Quick links